PetLife Pharmaceuticals, Inc. Convertible Notes Payable
PetLife Pharmaceuticals, Inc. had Convertible Notes Payable of $212.93 thousand as of 2018-02-28, per its 10-Q filed 2018-07-17.
Discontinued › Balance Sheet › Liabilities › Notes Payable
us-gaap:ConvertibleNotesPayable · last filed 2018-07-17
- 2018-02-28: Convertible Notes Payable $212.93K.
- 2017-11-30: Convertible Notes Payable $407.53K.
- 2017-08-31: Convertible Notes Payable $57.32K; Convertible Notes Payable as first filed $369.32K.
| Period end | Convertible Notes Payable | Convertible Notes Payable as first filed |
|---|---|---|
| 2018-02-28 | $212.93K 10-Q · filed 2018-07-17 | |
| 2017-11-30 | $407.53K 10-Q · filed 2018-01-22 | |
| 2017-08-31 | $57.32K 10-Q · filed 2018-07-17 | $369.32K 10-Q · filed 2018-01-22 |